BioAffinity Technologies Inc (BIAF) concluded trading on Thursday at a closing price of $0.36, with 190.74 million shares of worth about $68.67 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -63.75% during that period and on June 26, 2025 the price saw a gain of about 46.90%. Currently the company’s common shares owned by public are about 28.46M shares, out of which, 20.25M shares are available for trading.
Stock saw a price change of 43.33% in past 5 days and over the past one month there was a price change of 32.12%. Year-to-date (YTD), BIAF shares are showing a performance of -81.06% which decreased to -60.45% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.16 but also hit the highest price of $2.99 during that period. The average intraday trading volume for BioAffinity Technologies Inc shares is 12.57 million. The stock is currently trading 28.73% above its 20-day simple moving average (SMA20), while that difference is up 11.23% for SMA50 and it goes to -58.91% lower than SMA200.
BioAffinity Technologies Inc (NASDAQ: BIAF) currently have 28.46M outstanding shares and institutions hold larger chunk of about 1.80% of that.
The stock has a current market capitalization of $10.24M and its 3Y-monthly beta is at 2.52. It has posted earnings per share of -$0.72 in the same period. It has Quick Ratio of 0.53 while making debt-to-equity ratio of 0.92. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for BIAF, volatility over the week remained 17.89% while standing at 16.90% over the month.
Analysts are in expectations that BioAffinity Technologies Inc (BIAF) stock would likely to be making an EPS of -0.1 in the current quarter, while forecast for next quarter EPS is -0.09 and it is -0.18 for next year. For the current quarter EPS, analysts have given the company a lowest target -0.1 which is -0.1 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of -0.19 in the same quarter a year ago. Stock’s fiscal year EPS is expected to rise by 46.67% while it is estimated to increase by 55.00% in next year.
